REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - MEDTRONIC INC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

29/10/2014 10:11

RNS Number : 6912T
FIL Limited
07 October 2014
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
 FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
06-October-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities 
24,887,392 2.53

(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
3,500 0.00
Total
24,887,392 2.53
3,500 0.00
 
Please note that the above positions include a transfer out from our accounts for 29 shares.
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short

Number (%)
Number (%)
(63) Relevant securities 
 
 
(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
 
 
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
31,400
65.1954 USD/ Share
Buy
8,200
65.2074 USD/ Share
Buy
86,661
65.1908 USD/ Share
Buy
2,100
65.2276 USD/ Share
Buy
19,367
65.1172 USD/ Share
Buy
641
65.1969 USD/ Share
Buy
11,572
65.0966 USD/ Share
Buy
6,300
65.0794 USD/ Share
Buy
200,000
65.2499 USD/ Share
Buy
79,000
65.2004 USD/ Share
Buy
13,935
65.0992 USD/ Share
Buy
134,133
65.0518 USD/ Share
Buy
66,251
65.0307 USD/ Share
Buy
8,163
65.0597 USD/ Share
Buy
84,009
65.0217 USD/ Share
Buy
11,300
65.0550 USD/ Share
Buy
2,700
65.0922 USD/ Share
Buy
360
65.0386 USD/ Share
Buy
168,013
65.0022 USD/ Share
Buy
49,082
65.0076 USD/ Share
Buy
6,900
65.0039 USD/ Share
Buy
29,201
65.0132 USD/ Share
Buy
52,339
65.0534 USD/ Share
Buy
5,789
65.0384 USD/ Share
Buy
35,798
64.9040 USD/ Share
Buy
16,144
64.9375 USD/ Share
Buy
72,100
64.8250 USD/ Share
Buy
2,800
65.0611 USD/ Share
Buy
300
65.0725 USD/ Share
Buy
4,300
65.0524 USD/ Share
Buy
53,599
64.9805 USD/ Share
Buy
31,621
64.9662 USD/ Share
Buy
200
64.9400 USD/ Share
Buy
17,618
64.9724 USD/ Share
Buy
28,622
64.9579 USD/ Share
Buy
4,510
64.9567 USD/ Share
Buy
1,144
64.9798 USD/ Share
Buy
600
64.9850 USD/ Share
Buy
2,600
64.9700 USD/ Share
Buy
205
64.9605 USD/ Share
Buy
176,000
64.9499 USD/ Share
Buy
33,679
64.9981 USD/ Share
Buy
500,000
65.0500 USD/ Share
Sale
300
65.0500 USD/ Share
Buy
100
65.1230 USD/ Share
Sale
100
65.0300 USD/ Share
Sale
1
64.9000 USD/ Share
Sale
21
65.0500 USD/ Share
Sale
28
65.1000 USD/ Share
Buy
100
65.1200 USD/ Share
Buy
89
65.1100 USD/ Share
Buy
70
65.0500 USD/ Share
Buy
10
65.0100 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price 
Type, e.g. American, European etc.
Expiry 
date
Option money
paid/received per unit (Note 5) 







(ii) Exercising
Product name, e.g. call option
Number of securities 
Exercise price per unit (Note 5)


(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)


4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Call Option
Written
1,000
USD 65.00
American
18 October 2014
Date of disclosure
07 October 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISEZDLFBZBFLFBK